PT-141 (Bremelanotide)
PT-141, also known as Bremelanotide, is a synthetic peptide analog derived from the melanocortin peptide family. It is primarily studied in neuroscience and endocrine research due to its interaction with melanocortin receptors, which are involved in complex signaling pathways affecting central nervous system communication and cellular regulation.
In laboratory research, PT-141 is valued for its receptor-targeted activity, particularly its interaction with melanocortin receptor subtypes. These receptors are distributed throughout the central nervous system and peripheral tissues, making PT-141 a relevant tool for exploring peptide-mediated signaling mechanisms.
One of the defining characteristics of PT-141 is its enhanced stability and receptor selectivity compared to endogenous melanocortin peptides. This allows researchers to observe precise signaling effects over controlled experimental periods, supporting reproducible laboratory results.
PT-141 is frequently included in studies examining neuropeptide signaling and central nervous system modulation. Its activity provides insight into how targeted peptide-receptor interactions influence communication between neural circuits in experimental models.
The peptide is also studied for its effects on downstream molecular pathways associated with melanocortin signaling. Researchers investigate how PT-141 impacts gene expression, cellular activation, and receptor-mediated signal transduction under controlled conditions.
PT-141’s compact structure contributes to predictable molecular behavior in laboratory settings, making it suitable for comparative studies and protocol standardization.
Researchers often examine PT-141 alongside other melanocortin analogs to explore differences in receptor affinity, signaling intensity, and activation duration. This comparative approach helps clarify structure–activity relationships in peptide biology.
Unlike broad-acting compounds, PT-141 operates through selective receptor modulation, providing precise research control over the pathways of interest rather than widespread systemic effects.
PT-141 is also used in studies investigating central versus peripheral peptide signaling. Its receptor-targeted design allows differentiation between signaling effects in various tissue types within experimental models.
Because melanocortin signaling intersects multiple biological systems, PT-141 is frequently employed in systems-based research to study integrated cellular responses rather than isolated pathways.
The peptide’s well-characterized profile supports reproducibility and standardization in laboratory research. Its stability, selectivity, and receptor-targeted behavior make it a valuable tool for advanced neuroendocrine and peptide research.
PT-141 continues to attract scientific interest due to its precision, structural refinement, and relevance in understanding complex peptide-mediated signaling networks.
Its targeted design, predictable behavior, and receptor specificity make PT-141 an important research compound for studying central nervous system communication and peptide receptor biology.
New
PT-141 (Bremelanotide) 10mg
$58.00
PT-141, also known as Bremelanotide, is a synthetic peptide analog derived from the melanocortin peptide family. It is primarily studied in neuroscience and endocrine research due to its interaction with melanocortin receptors, which are involved in complex signaling pathways affecting central nervous system communication and cellular regulation.
Description
Shipping & Delivery
Related products
5-Amino-1MQ 50mg (60 Capsules)
5-amino-1MQ is a small molecule that blocks the activity of the enzyme called nicotinamide N-methyltransferase (NNMT). NNMT is a very important component in metabolism and energy and is predominantly active in fat tissue. By blocking NNMT, 5-amino-1MQ stimulates an increase in nicotinamide adenine dinucleotide (NAD+), a cofactor that is central to cellular metabolism, thereby increasing metabolic rate and activating a gene called sirtuin-1 (SIRT1).
SIRT1 is also known as the "longevity gene" because of its role in reducing the risk of diabetes, obesity, metabolic syndrome, atherosclerosis and other forms of cardiovascular disease, kidney disease, liver disease, neurodegeneration, and cancer. Research in mice given 5-amino-1MQ showed a 7% reduction in body mass over 10 days without any changes in food intake, compared to controls. Research has shown that decreasing NNMT may help shrink fat cells and reduce the size of fat deposits. 
AOD9604 6mg
AOD9604 is a modified version of the hGH fragment 176-191 peptide (contains a di-sulfide bridge) and thus a derivative of human growth hormone (hGH). Originally developed as a lipolytic (fat burning) compound, AOD9604 has shown benefit in studies of heart disease, osteoarthritis/cartilage repair, and metabolic syndrome. AOD9604 stimulates lipolysis (the breakdown or destruction of fat) and inhibits lipogenesis in animal studies.
BPC 157 500mcg (60 Capsules)
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. 
BPC-157 5mg
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. BPC-157, TB-500, GHK-Cu (Glow Blend)
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. 
Semaglutide 10
Semaglutide is a widely researched peptide-based compound recognized for its significant role in metabolic regulation and appetite control. It belongs to the class of GLP-1 receptor agonists, which are designed to mimic naturally occurring hormones involved in glucose metabolism and satiety signaling.
TB-500 (Thymosin Beta-4) (43aa) (2mg x 10 Vials = 20mg)
TB-500 (Thymosin Beta-4) is a 43 amino acid peptide sequence. In animal models, Thymosin Beta-4 has been shown to improve blood vessel growth, regulate wound healing, decrease inflammation, and reduce oxidative damage in the heart and central nervous system. Thymosin-beta-4 has a role in protection, tissue repair, regeneration and remodeling of injured or damaged tissues. It is also of active interest in anti-aging research.
Reviews
There are no reviews yet.